$82.32
+0.320 (+0.390%)
At Close: Jul 31, 2026
Dr Reddy’s Labs Signs Licensing Agreement For Gilead’s Remdesivir
12:09pm, Monday, 15'th Jun 2020
Dr Reddy's Laboratories Ltd. (RDY) announced that it has entered into a non-exclusive licensing agreement to manufacture and sell Gilead Sciences Inc.’s (GILD) coronavirus drug candidate remdesivir.
Eli Lilly starts trial of rheumatoid arthritis drug in COVID-19 patients
10:45am, Monday, 15'th Jun 2020
Eli Lilly and Co on Monday said it was launching a study of its rheumatoid arthritis drug baricitinib in patients hospitalized for COVID-19. Scientists at Lilly believe that baricitinib could help su
Sign In
Buy DIOD